$OPGN
OPGEN INC Stock $opgn

$opgn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000107997323000391 Filed on March 30, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$913.4K	$721.6K	$2.607M
YoY Change	94.45%	-49.38%	-39.45%
Cost Of Revenue	$592.4K	$536.0K	$3.320M
YoY Change	83.65%	-37.48%	16.54%
Gross Profit	$321.1K	$185.7K	-$712.3K
YoY Change	118.13%	-67.33%	-148.87%
Gross Profit Margin	35.15%	25.73%	-27.32%
Selling, General & Admin	$3.450M	$3.197M	$13.23M
YoY Change	-6.16%	-8.66%	-3.08%
% of Gross Profit	1074.56%	1721.71%
Research & Development	$1.813M	$1.552M	$8.173M
YoY Change	-21.74%	-45.64%	-25.09%
% of Gross Profit	564.63%	835.96%
Depreciation & Amortization	$350.5K	$335.2K	$1.643M
YoY Change	-31.85%	-44.74%	-39.47%
% of Gross Profit	109.15%	180.53%
Operating Expenses	$5.263M	$4.714M	$21.40M
YoY Change	-12.18%	-25.82%	-12.86%
Operating Profit	-$5.070M	-$4.528M	-$34.57M
YoY Change	-13.27%	-21.75%	48.53%
Interest Expense	$617.3K	-$599.2K	$3.256M
YoY Change	-164.44%	-38.93%	-32.15%
% of Operating Profit
Other Income/Expense, Net	-$666.5K	$0.00	-$2.716M
YoY Change			-76.36%
Pretax Income	-$5.737M	-$10.54M	-$37.28M
YoY Change	-15.68%	55.66%	7.25%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$5.737M	-$10.54M	-$37.28M
YoY Change	-15.68%	54.66%	7.12%
Net Earnings / Revenue	-628.02%	-1459.91%	-1429.96%
Basic Earnings Per Share	-$1.25		-$15.27
Diluted Earnings Per Share	-$1.25	-$3.86	-$15.27
COMMON SHARES
Basic Shares Outstanding	5.496M shares	53.70M shares	2.442M shares
Diluted Shares Outstanding	4.577M shares		2.442M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.039M	$7.440M	$7.440M
YoY Change	-77.04%	-79.38%	-79.38%
Cash & Equivalents	$7.039M	$7.440M	$7.440M
Short-Term Investments
Other Short-Term Assets	$1.456M	$1.356M	$1.356M
YoY Change	20.1%	8.45%	8.45%
Inventory	$3.645M	$3.646M	$1.345M
Prepaid Expenses
Receivables	$666.8K	$514.4K	$514.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.74M	$10.66M	$10.66M
YoY Change	-67.93%	-73.19%	-73.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.667M	$3.458M	$4.920M
YoY Change	-33.07%	-13.81%	-16.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$497.1K	$495.6K	$2.796M
YoY Change	-87.31%	-10.18%	-30.51%
Total Long-Term Assets	$15.77M	$15.16M	$15.16M
YoY Change	-48.74%	-52.52%	-52.52%
TOTAL ASSETS
Total Short-Term Assets	$10.74M	$10.66M	$10.66M
Total Long-Term Assets	$15.77M	$15.16M	$15.16M
Total Assets	$26.51M	$25.81M	$25.81M
YoY Change	-58.74%	-63.98%	-63.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$266.6K	$420.8K	$420.8K
YoY Change	-69.19%	-67.8%	-67.8%
Accrued Expenses	$1.436M	$1.526M	$3.001M
YoY Change	-61.46%	-22.36%	-25.84%
Deferred Revenue	$46.00K	$142.1K
YoY Change
Short-Term Debt	$4.959M	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$4.959M	$7.024M	$7.027M
YoY Change	-65.61%	-51.62%	-51.74%
Total Short-Term Liabilities	$8.636M	$10.59M	$10.59M
YoY Change	-54.58%	-46.82%	-46.82%
LONG-TERM LIABILITIES
Long-Term Debt	$5.358M	$4.851M	$4.851M
YoY Change	-32.67%	-32.44%	-32.44%
Other Long-Term Liabilities	$129.2K	$129.4K	$2.795M
YoY Change	-95.85%	-11.87%	-16.64%
Total Long-Term Liabilities	$129.2K	$129.4K	$7.646M
YoY Change	-98.83%	-11.87%	-27.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.636M	$10.59M	$10.59M
Total Long-Term Liabilities	$129.2K	$129.4K	$7.646M
Total Liabilities	$17.33M	$18.24M	$18.24M
YoY Change	-42.39%	-40.11%	-40.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$278.6M	-$272.8M
YoY Change		15.83%
Common Stock	$54.96K	$29.00K
YoY Change		-93.76%
Preferred Stock		$1.800M
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.177M	$7.576M	$7.576M
YoY Change
Total Liabilities & Shareholders Equity	$26.51M	$25.81M	$25.81M
YoY Change	-58.74%	-63.98%	-63.98%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$5.737M	-$10.54M	-$37.28M
YoY Change	-15.68%	54.66%	7.12%
Depreciation, Depletion And Amortization	$350.5K	$335.2K	$1.643M
YoY Change	-31.85%	-44.74%	-39.47%
Cash From Operating Activities	-$4.963M	-$3.995M	-$20.45M
YoY Change	-1.56%	5.44%	-4.79%
INVESTING ACTIVITIES
Capital Expenditures	$330.4K	$404.2K	$590.8K
YoY Change	-953.65%	-354.48%	-70.22%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$330.4K	-$404.2K	-$590.8K
YoY Change	753.65%	154.48%	-70.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$989.7K
YoY Change			-33.3%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$4.744M	1.011M	-$6.736M
YoY Change	-27160.18%	-93.44%	-114.19%
NET CHANGE
Cash From Operating Activities	-$4.963M	-3.995M	-$20.45M
Cash From Investing Activities	-$330.4K	-404.2K	-$590.8K
Cash From Financing Activities	$4.744M	1.011M	-$6.736M
Net Change In Cash	-$399.2K	-3.388M	-$28.70M
YoY Change	-92.17%	-129.55%	-227.4%
FREE CASH FLOW
Cash From Operating Activities	-$4.963M	-$3.995M	-$20.45M
Capital Expenditures	$330.4K	$404.2K	$590.8K
Free Cash Flow	-$5.293M	-$4.399M	-$21.04M
YoY Change	5.8%	21.18%	-10.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	opgn	Warrant Inducement Expense WarrantInducementExpense		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37367
CY2022	dei	Entity Registrant Name EntityRegistrantName	OPGEN, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1614015
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	9717 Key West Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockville
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20850
CY2022	dei	City Area Code CityAreaCode	(240)
CY2022	dei	Local Phone Number LocalPhoneNumber	813-1260
CY2022	dei	Security12b Title Security12bTitle	Common Stock
CY2022	dei	Trading Symbol TradingSymbol	OPGN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	25338288	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5495546	shares
CY2022	dei	Auditor Firm AuditorFirmId	596
CY2022	dei	Auditor Name AuditorName	CohnReznick LLP
CY2022	dei	Auditor Location AuditorLocation	Tysons, Virginia
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36080392	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	514372	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1172396	usd
CY2022Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	1345137	usd
CY2021Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	1239456	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18237601	usd
CY2021Q4	us-gaap	Liabilities Liabilities	30449453	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1355949	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1250331	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10655488	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	39742575	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457531	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4011748	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	90467	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1459413	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1814396	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7453007	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7440974	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14530209	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2300614	usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	3472337	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	495629	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	551794	usd
CY2022Q4	us-gaap	Assets Assets	25813149	usd
CY2021Q4	us-gaap	Assets Assets	71666533	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	420821	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1307081	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1097654	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1621788	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1526204	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1965845	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	142061	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	7023901	usd
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	14519113	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3364	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	43150	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377626	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	459792	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10591631	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19916769	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4850686	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	7176251	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	99498	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	228589	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	280	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3644	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2566138	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2977402	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	129368	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	146798	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2899911	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2899911	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2322511	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2322511	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	28999	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	23225	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	281167161	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	276149768	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-272824772	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-235541539	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-795840	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	585626	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41217080	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25813149	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71666533	usd
CY2022	us-gaap	Revenues Revenues	2607293	usd
CY2021	us-gaap	Revenues Revenues	4306031	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3319586	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2295828	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	104405	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	552620	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8173435	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10910679	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8884084	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9935963	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4344656	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3713263	usd
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	170714	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	37174414	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	27579067	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-34567121	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-23273036	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	259353	usd
CY2021	opgn	Warrant Inducement Expense WarrantInducementExpense	7755541	usd
CY2022	opgn	Interest And Other Income Expense InterestAndOtherIncomeExpense	46935	usd
CY2021	opgn	Interest And Other Income Expense InterestAndOtherIncomeExpense	45179	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37283233	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-34805712	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1642781	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2713907	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	2359219	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	3988755	usd
CY2022	us-gaap	Interest Expense InterestExpense	3256410	usd
CY2021	us-gaap	Interest Expense InterestExpense	4799331	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	379622	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	891223	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	113741	usd
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-129731	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2716112	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11488848	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37283233	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-34761884	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43828	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37283233	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-34805712	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7166752	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37283233	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-41972464	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-15.27
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-22.89
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2441580	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1833704	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37283233	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-34805712	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1381466	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1961556	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38664699	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36767268	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	21191255	usd
CY2021	opgn	Public Offering Of Common Stock And Warrants Net Of Issuance Costs PublicOfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	23473962	usd
CY2021	opgn	Public Offering Of Preferred Stock And Warrants Net Of Issuance Costs PublicOfferingOfPreferredStockAndWarrantsNetOfIssuanceCosts	13851259	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	7166752	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7166752	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1483833	usd
CY2021	opgn	Common Stock Warrant Exercises Net Of Issuance Costs CommonStockWarrantExercisesNetOfIssuanceCosts	9094172	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	255751	usd
CY2021	opgn	Inducement Expense Related To Warrant Reprice InducementExpenseRelatedToWarrantReprice	7755541	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	878575	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1961556	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-34805712	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41217080	usd
CY2022	opgn	Public Offering Of Common Stock And Warrants Net Of Issuance Costs PublicOfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	3082528	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	989704	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	950935	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1381466	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37283233	usd
CY2022	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	1582026	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	950935	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	878575	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-16000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	259353	usd
CY2021	opgn	Inducement Expense Related To Warrant Reprice InducementExpenseRelatedToWarrantReprice	7755541	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-113740	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	129731	usd
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	170714	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-587761	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	575123	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	728548	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2336714	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-151456	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-739429	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-814299	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-471824	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1287874	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	602605	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	139570	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-9808	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20449698	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21479277	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	590772	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1983614	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-590772	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1983614	usd
CY2021	opgn	Proceeds From Issuance Of Common Stock Warrants ProceedsFromIssuanceOfCommonStockWarrants	255751	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	989704	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1483833	usd
CY2022	opgn	Proceeds From Issuance Of Common Stock And Prefunded Warrants In Registered Offering Net Of S ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsInRegisteredOfferingNetOfS	3082528	usd
CY2021	opgn	Proceeds From Issuance Of Common Stock And Prefunded Warrants In Registered Offering Net Of S ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsInRegisteredOfferingNetOfS	23473962	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	9094172	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	13851259	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	10764763	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	441076	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	43150	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	266470	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6735681	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47451431	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-920376	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1463609	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28696527	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	22524931	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36632186	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14107255	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36632186	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1079113	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	895200	usd
CY2021	opgn	Noncash Or Part Noncash Acquisition Rou Assets Acquired Through Operating Leases NoncashOrPartNoncashAcquisitionROUAssetsAcquiredThroughOperatingLeases	615761	usd
CY2021	opgn	Beneficial Conversion Option On Convertible Preferred Stock BeneficialConversionOptionOnConvertiblePreferredStock	7166752	usd
CY2021	opgn	Inventory Transferred To Property And Equipment InventoryTransferredToPropertyAndEquipment	530638	usd
CY2022	opgn	Property And Equipment Transferred To Inventory PropertyAndEquipmentTransferredToInventory	152243	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	268000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	215000	shares
CY2022Q4	opgn	Warrant Expiry Period WarrantExpiryPeriod	five and one-half years
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, liquidity assumptions, revenue recognition, inducement expense related to warrant repricing, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, discount rates used to discount unpaid lease payments to present values, valuation of derivative financial instruments measured at fair value on a recurring basis, deferred tax assets and liabilities and related valuation allowance, the estimated useful lives of long-lived assets, and the recoverability of long-lived assets. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	551794	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36080392	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	551794	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7935659	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36632186	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2020	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	1172396	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1011476	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	866963	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37445	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	100801	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2596830	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3744029	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3645751	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4711793	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1694843	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	98064	usd
CY2022	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	The estimated service lives range from three to ten years.
CY2022	us-gaap	Depreciation Depreciation	830757	usd
CY2021	us-gaap	Depreciation Depreciation	1541561	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7518811	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7549773	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	4061280	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	3538025	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457531	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4011748	usd
CY2022	opgn	Finished Goods Inventory To Sell Or Use After Balance Sheets Date FinishedGoodsInventoryToSellOrUseAfterBalanceSheetsDate	12	pure
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15518000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7437206	usd
CY2022Q4	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	639820	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7440974	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1371424	usd
CY2021Q4	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	-383633	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14530209	usd
CY2022	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	5407699	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	725060	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8131.84	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	738002	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	738002	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	738002	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	738002	usd
CY2022Q4	opgn	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	701890	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3787076	usd
CY2022Q4	opgn	Finite Lived Intangible Assets Expected Amortization Expense FiniteLivedIntangibleAssetsExpectedAmortizationExpense	7440974	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7453007	usd
CY2020Q4	us-gaap	Goodwill Goodwill	8024729	usd
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-571722	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7453007	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-512458	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	424304	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	692701	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	401436	usd
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	396365	usd
CY2022	opgn	Tax Benefit Percentage TaxBenefitPercentage	0.50	pure
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1400000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	900000	shares
CY2022	us-gaap	Revenues Revenues	2607293	usd
CY2021	us-gaap	Revenues Revenues	4306031	usd
CY2022	us-gaap	Revenues Revenues	2607293	usd
CY2021	us-gaap	Revenues Revenues	4306031	usd
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9808	usd
CY2021	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	9808	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	142061	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142061	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	228589	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-113741	usd
CY2022	opgn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Effect Of Foreign Exchange Rates FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchangeRates	-15350	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	99498	usd
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	112852	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	129731	usd
CY2021	opgn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Effect Of Foreign Exchange Rates FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchangeRates	-13994	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	228589	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	170714	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	13489178	usd
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	25161855	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1614591	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3466491	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	11874587	usd
CY2021Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	21695364	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7023901	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	14519113	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	4850686	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	7176251	usd
CY2017Q2	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.04	pure
CY2019Q2	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	5000000	eur
CY2019Q2	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	5000000	eur
CY2022Q2	us-gaap	Payments For Loans PaymentsForLoans	700000	usd
CY2022	opgn	Payroll Costs Rent Obligations And Covered Utility Payments Term PayrollCostsRentObligationsAndCoveredUtilityPaymentsTerm	twenty-four
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	3256410	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	4799331	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2899911	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q1	opgn	Issuance Expire Term IssuanceExpireTerm	P5Y6M
CY2021Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	375000	shares
CY2021	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	375000	shares
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	85732	shares
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1030000.00	usd
CY2022	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	990000	usd
CY2022Q4	opgn	Aggregate Share Purchase AggregateSharePurchase	215000	shares
CY2022Q4	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3040000.00	usd
CY2022Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	1800000	usd
CY2022	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	950935	usd
CY2021	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	878575	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	83226	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	159.8
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y4M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	20750	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	39.8
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	18181	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	43.4
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	130	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	10887.4
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	85665	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	137.6
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	28125	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.61
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3237	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	31.11
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2956	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	641.78
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	107597	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	93.45
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	107597	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	93.45
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	50259	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	200.07
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	571282	usd
CY2022	opgn	Unrecognized Compensation Cost UnrecognizedCompensationCost	255000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1291213	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	810902	shares
CY2022	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	37300000	usd
CY2021	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	34800000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	43828	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43828	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	106624343	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	106839267	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106060462	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106088316	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.206	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	102095463	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	102388393	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2559479	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2559479	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	724265	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	498658	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	502575	usd
CY2022Q4	opgn	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	586067	usd
CY2021Q4	opgn	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	567624	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	659069	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	322538	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	106624343	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	106839267	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106060462	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106088316	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	178478	usd
CY2022Q4	opgn	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	-220040	usd
CY2021Q4	opgn	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	-225057	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	343841	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	347416	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.005	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.044	pure
CY2022	opgn	Effective Income Tax Rate Reconciliation Provision To Return Adjustment EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustment	0.005	pure
CY2021	opgn	Effective Income Tax Rate Reconciliation Provision To Return Adjustment EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustment	-0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.016	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.038	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.024	pure
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	106100000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	106100000	usd
CY2022	opgn	Tax Cuts And Jobs Act Of2017 Maximum Percentage Of Taxable Income In Which Operating Loss Permitted To Deduct TaxCutsAndJobsActOf2017MaximumPercentageOfTaxableIncomeInWhichOperatingLossPermittedToDeduct	0.80	pure
CY2022	opgn	Lost Or Expired No Lsin Shares LostOrExpiredNOLsinShares	-0.284	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.013	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001	pure
CY2022	opgn	Performed Outside PerformedOutside	P15Y
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1500000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1459413	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1814396	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	90467	usd
CY2022Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	1462913	usd
CY2021Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	1904863	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377626	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	459792	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3364	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	43150	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2566138	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2977402	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	280	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3644	usd
CY2022Q4	opgn	Lease Liability LeaseLiability	2947408	usd
CY2021Q4	opgn	Lease Liability LeaseLiability	3483988	usd
CY2022Q4	opgn	Operating And Finance Lease Liability Payments Remainder Of Fiscal Year OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	625555	usd
CY2022Q4	opgn	Operating And Finance Lease Liability Payments Due Year Two OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	632066	usd
CY2022Q4	opgn	Operating And Finance Lease Liability Payments Due Year Three OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	533795	usd
CY2022Q4	opgn	Operating And Finance Lease Liability Payments Due Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	378279	usd
CY2022Q4	opgn	Operating And Finance Lease Liability Payments Due Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive	388682	usd
CY2022Q4	opgn	Operating And Finance Lease Liability Payments Due After Year Five OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive	1737687	usd
CY2022Q4	opgn	Operating And Finance Lease Liability Payments Due OperatingAndFinanceLeaseLiabilityPaymentsDue	4296064	usd
CY2022Q4	opgn	Operating And Finance Lease Liabilities Undiscounted Excess Amount OperatingAndFinanceLeaseLiabilitiesUndiscountedExcessAmount	1348656	usd
CY2022Q4	opgn	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	2947408	usd
CY2022	us-gaap	Lease Cost LeaseCost	693807	usd
CY2021	us-gaap	Lease Cost LeaseCost	1430238	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.094	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.01	pure
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	605139	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1055595	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1701	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	15481	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	43150	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	266470	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	615761	usd
CY2022	opgn	Initial Agreement Period Description InitialAgreementPeriodDescription	36 months and was subsequently extended to January 31, 2025
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 post-reverse-split share for every 20 pre-reverse-split shares.
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-22.89
CY2021	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	opgn	Inducement Expense Related To Warrant Reprice InducementExpenseRelatedToWarrantReprice		usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	opgn	Proceeds From Issuance Of Common Stock Warrants ProceedsFromIssuanceOfCommonStockWarrants		usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants		usd
CY2022	opgn	Noncash Or Part Noncash Acquisition Rou Assets Acquired Through Operating Leases NoncashOrPartNoncashAcquisitionROUAssetsAcquiredThroughOperatingLeases		usd
CY2022	opgn	Beneficial Conversion Option On Convertible Preferred Stock BeneficialConversionOptionOnConvertiblePreferredStock		usd
CY2022	opgn	Inventory Transferred To Property And Equipment InventoryTransferredToPropertyAndEquipment		usd
CY2021	opgn	Property And Equipment Transferred To Inventory PropertyAndEquipmentTransferredToInventory		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	opgn	Lost Or Expired No Lsin Shares LostOrExpiredNOLsinShares		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent		pure
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001293818

Files In Submission

Name	View Source	Status
0001079973-23-000391-index-headers.html	Edgar Link	pending
0001079973-23-000391-index.html	Edgar Link	pending
0001079973-23-000391.txt	Edgar Link	pending
0001079973-23-000391-xbrl.zip	Edgar Link	pending
ex10x3.htm	Edgar Link	pending
ex21x1.htm	Edgar Link	pending
ex23x1.htm	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
ex4x23.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opgn-20221231.htm	Edgar Link	pending
opgn-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
opgn-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
opgn-20221231_def.xml	Edgar Link	unprocessable
opgn-20221231_lab.xml	Edgar Link	unprocessable
opgn-20221231_pre.xml	Edgar Link	unprocessable
opgn-20221231_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPGN
OPGEN INC Stock $opgn

2023 Q1 Form 10-K Financial Statement

#000107997323000391 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN OPGEN INC Stock $opgn

2023 Q1 Form 10-K Financial Statement

#000107997323000391 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN
OPGEN INC Stock $opgn